Technology has no borders; cooperation leads to mutual benefits.

On the morning of November 13, 2023, Dr. Nabil, a Doctor of Pharmacy and General Manager of Biorem Pharmaceutical Laboratory in Algeria, along with four core members of his technical team, visited the company for technical exchange and project cooperation investigation, accompanied by Li Xia, General Manager of Ningbo Hezhou Supply Chain Co., Ltd. Yao Xiaodong, General Manager of the company, and those in charge of the company's postdoctoral innovation practice base, the ‘Hai Zhi’ Plan workstation, and the expert workstation, warmly received them. Relevant personnel from the company's R&D, production, quality, sales, and scientific research technology platforms participated in the academic exchange meeting. The two sides explored industry customer pain points at the forefront of technology, exchanged ideas, discussed experiences, and sought directions and priorities for future technological development.

General Manager Yao Xiaodong delivered a welcome speech on behalf of the company, introducing the company's History, future plans, and measures for "taking a new path, opening a new situation, and creating a first-class enterprise." He explained the significance of this academic exchange and project investigation. He accompanied the guests on a tour of the company's production workshop and research laboratory, introduced the company's main products and semi-finished product export situation, and expressed the hope for broader and deeper project cooperation and collaborative innovation between the two sides in the future.

Dr. Nabil, representing Biorem Pharmaceutical Laboratory, spoke highly of the company's advanced independent R&D technology and automated production line operation system and expressed a strong desire to establish a cooperative relationship with the company. The company's technical director shared the company's highlights in global technological innovation and projects, and talent management practices; and presented the company's future outlook and considerations for the development of new products. The participating experts, based on their own work and research expertise, conducted in-depth exchanges and discussions with the visiting guests from the Algerian company on issues such as talent cultivation, project development, international exchange, and academic research. Dr. Nabil, Doctor of Pharmacy and General Manager of Biorem Pharmaceutical Laboratory in Algeria, shared his personal feelings about participating in this academic exchange and expressed his desire to conduct in-depth academic cooperation with the company in the areas of tetanus antitoxin product technology and the biopharmaceutical and health industry, and hoped that this visit would serve as an opportunity to further cooperate in international talent training.

During the open discussion session, participants engaged in lively exchanges and discussions on issues such as the challenges of cross-cultural management in the company's ‘Hai Zhi’ Plan workstation and the design of international talent management systems. The company provided detailed explanations to the questions raised by the personnel from the Algerian laboratory.

Participants expressed that they had gained a lot from this technical exchange. Both sides will further strengthen exchanges and enhance understanding, with a view to achieving higher-level and higher-quality cooperation in talent cultivation, academic research, and other fields in the future, promoting common development, and achieving win-win cooperation.

This technical exchange meeting showcased the company's latest technological development directions and achievements. The experts from Algeria brought new ideas, new trends, new technologies, and new experiences, injecting new vitality into the company's technological development. The company will combine future development strategic needs with enterprise development strategies, and combine cutting-edge technology research with interdisciplinary innovation in production, education, and research, daring to innovate in concepts, ideas, and cognition, and market-oriented to create a "high-quality and high-efficiency" biopharmaceutical industry, achieving sustainable development of science and technology through new technologies, new materials, and new processes. The company will further enhance its sense of urgency and mission in technological innovation, give full play to the innovative role of the technology platform, further promote the two-way integration of the technological innovation chain and the industrial chain, and make technological innovation a shining business card for the company's high-quality development.